Karyopharm Therapeutics Inc. — Investor Relations & Filings
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for cancer. The company's core scientific approach is centered on nuclear export inhibition, a mechanism that targets the transport of proteins within the cell's nucleus to combat cancer. Its primary efforts are directed towards developing treatments for hematologic malignancies, including multiple myeloma and diffuse large B-cell lymphoma, as well as various solid tumors. Karyopharm aims to address areas of high unmet medical need by pioneering first-in-class therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-05-04 | English | |
| S-3 - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-05-04 | English | |
| ARS - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-04-13 | English | |
| DEF 14A - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-04-13 | English | |
| 8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-03-27 | English | |
| 8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer) | 2026-03-24 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Karyopharm Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34529/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34529 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34529 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34529 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34529}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Karyopharm Therapeutics Inc. (id: 34529)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.